Mirae Asset Global Investments
SAGE

Mirae Asset Global Investments’s Sage Therapeutics SAGE Stock Holding History

Mirae Asset Global Investments’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,419
Closed -$22.1K – 1690
2025
Q2 		$22.1K Buy
2,419
+362
+18% +$2.66K ﹤0.01% 1387
2025
Q1 		$17K Buy
2,057
+18
+0.9% +$132 ﹤0.01% 1401
2024
Q4 		$11.3K Sell
2,039
-169
-8% -$1.03K ﹤0.01% 1497
2024
Q3 		$16.1K Buy
2,208
+411
+23% +$3.76K ﹤0.01% 1462
2024
Q2 		$19.2K Sell
1,797
-36,771
-95% -$471K ﹤0.01% 1382
2024
Q1 		$1.3M Buy
38,568
+1,693
+5% +$39.1K ﹤0.01% 1400
2023
Q4 		$799K Sell
36,875
-2,708
-7% -$53.7K ﹤0.01% 1734
2023
Q3 		$815K Buy
39,583
+8,561
+28% +$247K ﹤0.01% 1630
2023
Q2 		$1.46M Sell
31,022
-1,659
-5% -$82.5K ﹤0.01% 1370
2023
Q1 		$1.37M Buy
32,681
+6,247
+24% +$269K ﹤0.01% 1382
2022
Q4 		$1.01M Buy
26,434
+23
+0.1% +$878 ﹤0.01% 1491
2022
Q3 		$1.03M Buy
26,411
+10,003
+61% +$387K ﹤0.01% 1461
2022
Q2 		$530K Buy
+16,408
New +$550K ﹤0.01% 1719
2021
Q2 		– Sell
-3,998
Closed -$300K – 1732
2021
Q1 		$300K Sell
3,998
-816
-17% -$66.9K ﹤0.01% 1416
2020
Q4 		$417K Buy
4,814
+380
+9% +$28K ﹤0.01% 1366
2020
Q3 		$271K Buy
+4,434
New +$225K ﹤0.01% 1356
2020
Q2 		– Sell
-10,126
Closed -$291K – 1513
2020
Q1 		$291K Sell
10,126
-2,953
-23% -$171K ﹤0.01% 1207
2019
Q4 		$945K Buy
13,079
+2,475
+23% +$304K 0.01% 981
2019
Q3 		$1.49M Buy
10,604
+493
+5% +$82.5K 0.01% 791
2019
Q2 		$1.85M Buy
10,111
+527
+5% +$89.9K 0.01% 722
2019
Q1 		$1.52M Buy
9,584
+908
+10% +$131K 0.01% 705
2018
Q4 		$831K Buy
8,676
+239
+3% +$27.4K 0.01% 819
2018
Q3 		$1.19M Buy
8,437
+1,391
+20% +$215K 0.01% 783
2018
Q2 		$1.1M Sell
7,046
-22
-0.3% -$3.45K 0.02% 493
2018
Q1 		$1.14M Buy
7,068
+1,118
+19% +$190K 0.01% 469
2017
Q4 		$980K Buy
5,950
+1,638
+38% +$159K 0.01% 480
2017
Q3 		$269K Sell
4,312
-18,000
-81% -$1.41M ﹤0.01% 606
2017
Q2 		$1.78M Hold
22,312
– – 0.03% 329
2017
Q1 		$1.59M Buy
22,312
+3,654
+20% +$214K 0.03% 313
2016
Q4 		$953K Sell
18,658
-2,153
-10% -$101K 0.02% 334
2016
Q3 		$959K Buy
+20,811
New +$847K 0.02% 352

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mirae Asset Global Investments's SAGE Position: Q3 2025 in Review

Mirae Asset Global Investments sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 2,419 shares — an estimated $22.1K sold.

Mirae Asset Global Investments first reported a position in SAGE in Q3 2016 and held it in 31 quarters. The position peaked at $1.85M in Q2 2019. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • Mirae Asset Global Investments reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Mirae Asset Global Investments sold 2,419 Sage Therapeutics shares in Q3 2025, an estimated $22.1K.
  • Mirae Asset Global Investments first reported a position in Sage Therapeutics in Q3 2016 and held it in 31 quarters.
  • Mirae Asset Global Investments's Sage Therapeutics position peaked at $1.85M in Q2 2019.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Mirae Asset Global Investments's 13F filing for Q3 2025, filed 3 Nov 2025.